DENVER, Colo., 19 July, 2024 (247marketnews.com) – (Nasdaq:SILO) are discussed in this article.
Silo Pharma, Inc. (Nasdaq:SILO) has recently experienced a surge in stock trading activity, with pre-market trading indicating a bullish trend at $2.379 per share, reflecting a notable increase from the previous session’s close price of $3.47. The heightened trading volume of 6.3 million shares underscores the market’s interest in Silo Pharma, Inc., signaling potential upward momentum with a change percentage of 20.61% from market open to present.
In a strategic move to propel its drug development endeavors, Silo Pharma has successfully concluded definitive agreements for a registered direct offering of 763,638 shares of common stock at $2.75 per share. This offering aligns with Nasdaq regulations, highlighting the company’s commitment to advancing its groundbreaking formulations and drug delivery systems for conventional therapeutics and psychedelic treatments. Concurrently, the company will issue unregistered warrants for the purchase of up to 763,638 common stock shares, priced at $2.75 per share, with immediate exercisability post-issuance and a five-year validity period.
The anticipated closing date for this offering is set for July 22, 2024, subject to standard closing conditions. This milestone transaction signifies Silo Pharma’s dedication to driving pharmaceutical research and development forward, positioning it as a key player in the evolving biopharmaceutical landscape. As Silo Pharma continues its trajectory of innovation and growth, stakeholders are closely monitoring its progress and strategic initiatives, anticipating further advancements in the realm of drug discovery and delivery.
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 Market News, Inc Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com